Connect your AI

Tactile Systems Technology TCMD Price / book

Price / book at other companies

Viemed Healthcare, Inc.VMD

2.5×+0.3×

AngioDynamicsANGO

2.7×+0.7×

Merit Medical SystemsMMSI

2.5×-1.8×

SolventumSOLV

2.3×-1.8×

MiMedx GroupMDXG

2.4×-3.1×

United TherapeuticsUTHR

4.4×+2.4×

Other financials

Income statement

Revenue$75.3M+22.8%

Gross profit$57.6M+27.1%

Operating income-$1.5M+66.2%

Net income-$1.8M+40.7%

EPS (diluted)-$0.08+38.5%

Balance sheet

Cash & equivalents$75.0M-10.3%

Total debt$15.2M-62.7%

Total equity$217.9M+5.9%

Total assets$272.1M-2.9%

Cash flow

Operating cash flow-$339.0K-181%

CapEx$821.0K+117%

Free cash flow-$1.2M-3,153%

Valuation

Market cap$631.58M+172%

Enterprise value$571.76M+203%

P/E31.1×+16.8×

P/S1.8×+1.0×

Profitability

Gross margin76.4%+1.8pp

Operating margin9.4%+2.4pp

Net margin5.9%+0.4pp

FCF margin11.4%-1.5pp

Returns & leverage

Return on equity9.6%+1.5pp

Debt / equity0.1×-0.1×

Current ratio4.2×-0.3×

Where this comes from

Calculated from Tactile Systems Technology’s reported figures.

market cap/total stockholders equity=2.7×

Based on the most recent quarter.

The official record: Tactile Systems Technology’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tactile Systems Technology's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Tactile Systems Technology's price / book?: Tactile Systems Technology (TCMD) reported price / book of 2.7× in Q1 2026.
How has Tactile Systems Technology's price / book changed year-over-year?: Tactile Systems Technology's price / book increased by 79.3% year-over-year, from 1.5× to 2.7×.
What is the long-term trend for Tactile Systems Technology's price / book?: Over 5 years (2020 to 2025), Tactile Systems Technology's price / book has grown at a -16.2% compound annual growth rate (CAGR), from 7.1× to 3×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.